Hepatitis Blood Test Results: Antibodies vs Infection

Screening vs confirmatory hepatitis blood tests

Screening tests are built for sensitivity, not final diagnosis. A lab may call something a hepatitis screen even if it omits HBV DNA and HCV RNA, which is why patients should compare the listed markers with a comprehensive panel explainer. In my experience, the missing reflex test matters more than the first positive screen.

A 29-year-old nurse recently sent us a report showing anti-HBs 146 mIU/mL and worried she had hepatitis B. She was actually immune after vaccination: anti-HBs 10 mIU/mL or higher is usually protective, and vaccine-induced immunity gives anti-HBs positive with anti-HBc negative. That pattern is reassurance, not infection.

The opposite mistake is common with hepatitis C. In our analysis of more than 2 million uploaded reports across 127+ countries, one of the commonest false alarms is HCV antibody reactive with HCV RNA not detected; that combination usually means past cleared infection, prior successful treatment, or a screening false positive. Most patients find that distinction changes the whole emotional tone of the visit.

What a hepatitis panel blood test usually includes

The ordering context changes the panel. A primary care screen may look lean, while an abnormal-liver workup often adds the enzymes explained in our blood chemistry panel guide, plus bilirubin, albumin, and INR. Pregnancy panels are different again, because maternal HBsAg matters even if the mother feels well.

Reflex testing is the practical difference that patients rarely hear about. If HCV antibody is reactive and the lab has enough stored serum, a reflex HCV RNA PCR can save 2 to 7 days compared with bringing the patient back; when the tube volume is too low, the portal may look incomplete rather than negative. Our lab timeline article explains why confirmatory molecular testing almost always takes longer than the first immunoassay.

Some European labs report anti-HBs in IU/L instead of mIU/mL; numerically, they are equivalent. And not every result appears in the main portal view, which is why many people still end up reading the PDF line by line with our how to read blood test results walkthrough.

When antibodies mean exposure, immunity, or a false positive

The biology is pretty straightforward once you separate the classes. HAV IgM points toward recent hepatitis A, total anti-HAV usually means past infection or vaccination, anti-HBs means protection, and HCV antibody indicates natural exposure because there is no hepatitis C vaccine. Total anti-HBc is the key clue that a person encountered real hepatitis B virus at some point.

False positives do happen. Autoimmune conditions, recent IVIG, pregnancy, and very low-prevalence screening settings can all lower the positive predictive value of an isolated antibody result, which is why antibody tests sit beside the broader context in our immune function clues article. Autoimmune cross-reactivity is one reason we also review unexpected positives through the lens of an autoimmune panel review.

I see this pattern most in patients on B-cell-depleting drugs such as rituximab. They may fail to make expected antibodies, so a negative or weak serology panel can falsely reassure you while HBV DNA is the test that actually answers the question. That is one of those areas where context matters more than the checkbox.

How hepatitis A results differ from B and C

Most symptomatic adults develop HAV IgM around the time jaundice or nausea begins, not on day 1 after exposure. The antibody can remain positive for 3 to 6 months, sometimes longer, so a positive IgM does not tell you the exact day infection started.

The trap is the weak positive in someone who feels fine. I have seen false-positive HAV IgM with Epstein-Barr virus, CMV, and autoimmune liver disease, so I look hard at ALT, AST, and the broader pattern in the liver function test guide before I call it acute hepatitis A.

When hepatitis A is real, ALT and AST can climb well above 1000 IU/L, and bilirubin often rises later. If the only positive marker is total anti-HAV, that is usually good news—immunity, not disease. For the yellow-eye question patients always ask, our bilirubin thresholds guide explains why jaundice often starts once total bilirubin reaches roughly 2.5 to 3.0 mg/dL.

How to read a hepatitis B blood test pattern

CDC's 2023 recommendation favors a triple screen—HBsAg, anti-HBs, and total anti-HBc—for adults who have not been previously screened (Schillie et al., 2023). Anti-HBs 10 mIU/mL or higher, measured 1 to 2 months after completing the vaccine series, usually shows protective response, and Kantesti AI applies the same rules described in our medical validation standards.

Acute HBV usually looks like HBsAg positive with IgM anti-HBc positive. HBsAg persisting longer than 6 months defines chronic hepatitis B, and that threshold remains central in AASLD guidance (Terrault et al., 2018). HBV DNA adds the piece patients really want to know—whether the virus is replicating now and roughly how actively.

Here is the pattern I never ignore before immunosuppression: HBsAg negative, anti-HBs negative, anti-HBc positive. That isolated core antibody can mean false positivity, remote infection with waned surface antibody, occult HBV, or the short window phase of acute infection, and it deserves more respect than a casual portal comment. If liver tests are also off, review the broader picture in our elevated liver enzymes guide.

When HBV DNA changes the conversation

HBV DNA above 20,000 IU/mL in an HBeAg-positive adult, or above 2,000 IU/mL in an HBeAg-negative adult with elevated ALT, often shifts the discussion from watchful follow-up toward treatment evaluation. The exact cutoff is not the whole story—fibrosis, age, family history of liver cancer, pregnancy plans, and coinfection all matter. Total anti-HBc also tends to remain positive for life after natural infection, which is why vaccine immunity and past infection are not interchangeable.

How a hepatitis C blood test separates exposure from infection

Timing explains a lot of confusing reports. HCV RNA can appear about 1 to 2 weeks after exposure, whereas HCV antibody often takes 8 to 11 weeks, so an early test can be RNA positive and antibody negative—much like the timing problem we explain in our HIV window-period guide.

About 15% to 45% of people clear acute hepatitis C without treatment, so antibody may stay positive for life even when RNA disappears. The same is true after successful treatment: antibody remains positive, and EASL recommends checking for cure with HCV RNA 12 weeks after therapy rather than repeating the antibody (European Association for the Study of the Liver, 2020).

Some regions use HCV core antigen when PCR access is limited. In my experience it is clinically useful, but it becomes less sensitive at low viral loads—roughly below 3000 IU/mL—so a negative core antigen does not fully exclude low-level viremia. Kantesti AI flags that nuance because a bland nonreactive label can mislead people who recently tested positive elsewhere. For a broader look at why reference comments mislead, see our normal-range pitfalls article.

After cure, what stays positive?

A cured patient usually stays anti-HCV positive for years, often lifelong. Never use antibody alone to check whether direct-acting antivirals worked. The post-treatment milestone that matters is SVR12, meaning HCV RNA not detected 12 weeks after therapy ends.

When to repeat testing after a recent exposure

A man once asked me whether a negative hepatitis panel 5 days after a travel-related tattoo meant he was in the clear. Not really. For hepatitis C, I would trust an early RNA far more than an antibody at day 5, and for hepatitis B I want to know baseline vaccine status before I interpret anything.

Occupational follow-up commonly repeats testing at about 6 weeks, 3 months, and sometimes 6 months, depending on the virus, source status, and whether baseline immunity is documented. Use the same lab when you can. Even small assay differences make trend reading harder, which is why our blood test comparison guide pushes consistency over shopping around.

Post-vaccine anti-HBs should usually be checked 1 to 2 months after the last dose in healthcare workers, dialysis patients, and some immunocompromised adults—not years later when the titer may have faded. Pregnancy adds urgency because maternal HBsAg status directs newborn prophylaxis within 12 hours of birth, as we discuss in our prenatal blood tests guide.

Why ALT, AST, and bilirubin cannot confirm hepatitis alone

The upper limit printed by the lab is not always the most useful cutoff. In chronic hepatitis B, AASLD has long used lower true-normal ALT thresholds—about 35 IU/L for men and 25 IU/L for women—which is why an ALT of 42 IU/L may deserve attention even if the portal marks it normal. Our ALT guide explains why reference intervals can be too forgiving.

An AST/ALT ratio above 2 pushes alcohol effect higher on my list, while ALT well above AST is more typical of classic viral or fatty-liver injury. And context beats pattern alone: the 52-year-old marathon runner with AST 89 IU/L after a race is a very different patient from someone with HBsAg positive and dark urine. Our AST/ALT ratio article walks through that reasoning.

When ALT or AST exceeds roughly 1000 IU/L, the shortlist becomes narrower—acute viral hepatitis, ischemic injury, acetaminophen toxicity, and autoimmune hepatitis rise fast. GGT and ALP shift the story toward bile flow. For the cholestatic side of the pattern, our GGT guide covers why enzyme clusters matter more than one isolated number.

The most confusing hepatitis results I see in practice

Isolated anti-HBc is common enough that I never dismiss it. In adults from higher-prevalence regions it often represents old hepatitis B with waned anti-HBs, not a lab accident, and before rituximab or stem-cell therapy I usually want more than reassurance from a portal message.

There is another twist: transient HBsAg positivity has been reported for up to about 18 days after hepatitis B vaccination if the blood draw is too soon. I have only seen this once, but it is memorable. Thomas Klein, MD, and our physicians on the Medical Advisory Board built these edge cases into Kantesti's explanation layer because patients deserve more than positive equals infected.

Weak HCV antibody reactivity with negative RNA is another classic false alarm, especially in low-prevalence screening such as routine employment or pregnancy testing. If the result came through a portal, download the full report and verify whether reflex RNA was actually performed; our results-access guide shows where labs hide that detail.

What to do next with positive hepatitis results

Get faster medical review if hepatitis results travel with jaundice, confusion, easy bruising, persistent vomiting, or bilirubin above about 3 mg/dL. Most stable outpatients are not emergencies, but pregnancy, cirrhosis, HIV, planned chemotherapy, and transplant history lower my threshold to act quickly.

Our free interpretation demo lets you upload a PDF or photo, and Kantesti AI sorts screening markers from confirmatory markers in about 60 seconds. If you want the technical side, our PDF upload guide explains how we read lab layouts from different countries and why the model asks for the exact marker names rather than guessing.

If you are new to us, read more about Kantesti and how our medical team reviews YMYL topics. Bottom line: the safest question after any positive hepatitis blood test is still the simplest one—Which result proves virus is present now? That is the question I come back to, every time.

Frequently Asked Questions